Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atila BioSystems
Sunnyvale, California, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Atila BioSystems is a commercial molecular diagnostics company providing more than 100 CE-IVD/clinical and RUO assays based on proprietary high-multiplex nucleic acid amplification platforms, including COVID-19, HPV, STI, NIPT and oncology liquid biopsy panels, used mainly in clinical laboratories and research settings.
- Therapeutic areas
- OncologyWomen's HealthInfectious Diseases
- Modalities
- DeviceDiagnostic assayMolecular diagnostic
- Industry
- Molecular Diagnostics
02
Partnerships
Stilla Technologies (co-development and global co-marketing of high-plex digital PCR liquid biopsy kits for oncology on the naica system)
Beyond the preview
Go deeper on Atila BioSystems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atila BioSystems.